DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Hong Kong
  • /
  • Consumer Retailing
Author Program NEWCreate Narrative
6618 logo

JD Health International Inc. Stock Price

SEHK:6618 Community·HK$115.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

6618 Share Price Performance

HK$36.28
36.28 (0.00%)
​
HK$68.17
Fair Value
HK$36.28
36.28 (0.00%)
46.8% undervalued intrinsic discount
HK$68.17
Fair Value
Price HK$36.28
AnalystConsensusTarget HK$68.17
AnalystHighTarget HK$91.27
AnalystLowTarget HK$49.44
Tue, 18 Aug 26
Fair ValueHK$68.17
Share Pricen/a

6618 Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value HK$68.17 46.8% undervalued intrinsic discount

Leadership Transition And Digital Healthcare Trends Will Shape Upcoming Performance

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value HK$91.27 60.2% undervalued intrinsic discount

China's Digital Adoption And Aging Population Will Boost Telemedicine Demand

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value HK$49.44 26.6% undervalued intrinsic discount

Rising Chinese Regulatory Burdens Will Strain Digital Healthcare

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
6618 logo
JD Health International
46.8% undervalued intrinsic discount

Leadership Transition And Digital Healthcare Trends Will Shape Upcoming Performance

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 18 Aug
Read Narrative
6618 logo
JD Health International
60.2% undervalued intrinsic discount

China's Digital Adoption And Aging Population Will Boost Telemedicine Demand

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 4 Aug
Read Narrative
6618 logo
JD Health International
26.6% undervalued intrinsic discount

Rising Chinese Regulatory Burdens Will Strain Digital Healthcare

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 20 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
6618 logo

6618: Upcoming Interim Results And Dividend Decision Will Support Future Margin Upside

Fair Value: HK$68.17 46.8% undervalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
6618 logo

6618: Share Repurchases Will Support Future Upside Potential

Fair Value: HK$91.27 60.2% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
6618 logo

6618: Share Repurchase Program Will Support Dividend Prospects And Undervalued Outlook

Fair Value: HK$49.44 26.6% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Flawless balance sheet and undervalued.

0 Risks
4 Rewards
View Full Analysis

JD Health International Inc. Key Details

CN¥79.0b

Revenue

CN¥59.0b

Cost of Revenue

CN¥20.0b

Gross Profit

CN¥13.8b

Other Expenses

CN¥6.2b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
1.95
25.30%
7.86%
0%
View Full Analysis

About 6618

Founded
2014
Employees
6018
CEO
Cao Dong
WebsiteView website
ir.jdhealth.com

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People’s Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

Recent 6618 News & Updates

User avatar
Narrative Update • Aug 18

6618: Upcoming Interim Results And Dividend Decision Will Support Future Margin Upside

Analysts have reduced their price target for JD Health International to HK$68.17 from HK$71.78, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News JD Health International has scheduled a board meeting for Aug 13, 2026.
User avatar
Narrative Update • Aug 04

6618: Share Repurchases Will Support Future Upside Potential

Analysts have nudged their fair value estimate for JD Health International higher from about HK$89.24 to roughly HK$91.27, reflecting updated assumptions for revenue growth, profit margins, and future P/E levels. What's in the News for JD Health International A board meeting is scheduled for August 13, 2026, to review and approve the unaudited interim results for JD Health International and its subsidiaries for the six months ended June 30, 2026, and to consider a potential interim dividend.

Recent updates

No updates

JD Health International Inc. Competitors

1768 logo

Busy Ming Group

Symbol: SEHK:1768
Market cap: HK$79.0b
241 logo

Alibaba Health Information Technology

Symbol: SEHK:241
Market cap: HK$49.5b
1797 logo

East Buy Holding

Symbol: SEHK:1797
Market cap: HK$27.3b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide